Prognostic significance of COX-2 and β-catenin in colorectal carcinomaFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 17 July 2013

References

• R.MidgleyD.KerrColorectal cancerLancet3531999391399
   PubMed Web of Science ®Google Scholar
• A.A.Abou-ZeidW.KhafagyD.M.MarzoukA.AlaaI.MostafaM.A.ElaColorectal cancer in EgyptDis Colon Rectum45200212551260
   PubMed Web of Science ®Google Scholar
• A.S.SolimanM.L.BondyB.LevinColorectal cancer in Egyptian patients under 40 years of ageInt J Cancer7119972630
   PubMed Web of Science ®Google Scholar
• A.S.SolimanM.L.BondyB.LevinS.El-BadawyH.KhaledA.HablassInt. J. Cancer771998811816
   PubMed Web of Science ®Google Scholar
• M.J.ThunM.M.NamboodiriC.W.HeathJr.Aspirin use and reduced risk of fatal colon cancerN Engl J Med325199115931596
   PubMed Web of Science ®Google Scholar
• J.M.HerendeenC.LindleyUse of NSAIDs for the chemoprevention of colorectal cancerAnn Pharmacother3711200316641674
   PubMed Web of Science ®Google Scholar
• R.BenamouzingB.UzzanJ.LittleS.ChaussadeLow dose aspirin, COX-inhibition and chemoprevention of colorectal cancerCurr Top Med Chem552005493503
   Web of Science ®Google Scholar
• E.FlossmannP.M.RothwellEffect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesLancet3699573200716031613
   PubMed Web of Science ®Google Scholar
• K.CooperH.SquiresC.CarrollD.PapaioannouA.BoothR.F.LoganChemoprevention of colorectal cancer: systematic review and economic evaluationHealth Technol Assess143220101206
   Web of Science ®Google Scholar
• S.J.MyungI.H.KimRole of prostaglandins in colon cancerKorean J Gastroenterol5152008274279
   Google Scholar
• R.PoonR.SmitsC.LiS.Jagmohan-ChangurM.KongS.CheonCyclooxygenase two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumour)Oncogene202001451460
   PubMed Web of Science ®Google Scholar
• J.GrodenA.ThliverisW.SamowitzM.CarlsonL.GelbertIdentification and characterization of the familial adenomatous polyposis coli geneCell661991589600
   PubMed Web of Science ®Google Scholar
• N.BarkerH.CleversMining the Wnt pathway for cancer therapeuticsNat Rev Drug Discov520069971014
   PubMed Web of Science ®Google Scholar
• K.WillertKAJonesWnt signaling: is the party in the nucleus?Genes Dev20200613941404
   PubMed Web of Science ®Google Scholar
• M.GuarinoB.RubinoG.BallabioThe role of epithelial-mesenchymal transition in cancer pathologyPathology3932007305318
   PubMed Web of Science ®Google Scholar
• W.S.MoonH.S.ParkH.LeeR.PaiA.S.TarnawskiK.R.KimCo-expression of COX-2, C-met and beta-catenin in cells forming invasive front of gallbladder cancerCancer Res Treat3732005171176
   Google Scholar
• S.R.HamiltonL.A.AaltonenWorld Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System2000IARC PressLyon
   Google Scholar
• S.B.EdgeC.C.ComptonThe American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnn Surg Oncol176201014711474
   PubMed Web of Science ®Google Scholar
• S.M.HsuM.RanteH.FaugerUse of Avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) proceduresJ Histochem Cytochem291981577580
   PubMed Web of Science ®Google Scholar
• M.YukawaT.FujimoriS.MaedaM.TabuchiK.NagasakoComparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumoursGut35199412581261
   PubMed Web of Science ®Google Scholar
• M.P.CharalambousT.LightfootV.SpeirsK.HorgansN.J.GooderhamExpression of COX-2, NF-kB-p65, NF-kB-p50 and IKKa in malignant and adjacent normal human colorectal tissueBr J Cancer1012009106115
   PubMed Web of Science ®Google Scholar
• J.R.JassK.G.BidenM.C.CummingsL.A.SimmsM.WalshE.SchochCharacterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathwaysJ Clin Pathol521999455460
   PubMed Web of Science ®Google Scholar
• E.LeslieJ.GeoffreyM.JamesStatistical Analysis, Interpretation and Uses of Medical Statisticsfourth ed.1991Oxford Scientific Publications pp. 411–416
   Google Scholar
• A.W.WuJ.GuJ.F.JiZ.F.LiG.W.XuRole of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients’s prognosisWorld J Gastroenterol99200319901994
   PubMed Web of Science ®Google Scholar
• Y.-E.JooH.-S.KimS.-W.MinW.-S.LeeC.-H.ParkC.-S.ParkExpression of Cyclooxygenase-2 protein in colorectal carcinomasInt J Gastroint Cancer311–32002147154
   Google Scholar
• J.DimbergA.SamuelssonA.HuganderDifferential expression of cyclooxygenase-2 in human colorectal cancerGut451999730732
   PubMed Web of Science ®Google Scholar
• F.A.SinicropeM.LemoineL.XiReduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancersGastroenterology1171999350358
   PubMed Web of Science ®Google Scholar
• D.HwangD.ScollardJ.ByrneExpression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancerJ Natl Cancer Inst901998455460
   PubMed Web of Science ®Google Scholar
• H.WolffK.SaukkonenS.AnttilaExpression of cyclooxygenase-2 in human lung carcinomaCancer Res58199849975001
   PubMed Web of Science ®Google Scholar
• K.UefujiT.IchikuraH.MochizukiExpression of cyclooxygenase-2 protein in gastric adenocarcinomaJ Surg Oncol691998168172
   PubMed Web of Science ®Google Scholar
• K.C.ZimmermannM.SarbiaA.A.WeberCyclooxygenase-2 expression in human esophageal carcinomaCancer Res591999198204
   PubMed Web of Science ®Google Scholar
• K.M.SheehanK.SheahanD.P.O’DonoghueThe relationship between cyclooxygenase-2 expression and colorectal cancerJAMA282199912541257
   PubMed Web of Science ®Google Scholar
• H.SanoY.KawahitoR.L.WilderA.HashiramotoS.MukaiK.AsaiExpression of cyclooxygenase-1 and -2 in human colorectal cancerCancer Res55199537853789
   PubMed Web of Science ®Google Scholar
• S.-J.KimD.-S.ImS.-H.KimJ.-H.RyuS.-G.HwangJ.-K.SeongB-Catenin regulates expression of cyclooxygenase-2 in articular chondrocytesBiochem Biophys Res Commun2962002221226
   PubMed Web of Science ®Google Scholar
• M.IwamotoD.J.AhnenW.A.FranklinT.H.MaltzmanExpression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissuesCarcinogenesis21200019351940
   PubMed Web of Science ®Google Scholar
• S.K.HongY.A.GulH.IthninA.TalibH.F.SeowExpression of β-catenin, COX-2 and iNOS in colorectal cancer: relevance of COX-2 and iNOS inhibitors for treatment in MalaysiaAsian J Surg27120041017
   Google Scholar
• B.M.GhadimiJ.BehrensI.HoffmannW.HaenschW.BirchmeierP.M.SchlagImmunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signalingEur J Cancer35119996065
   Web of Science ®Google Scholar
• J.WlodarczykM.StolteJ.MuellerE-cadherin, beta-catenin and stromelysin-3 expression in de novo carcinoma of the colorectumPol J Pathol5232001119124
   Google Scholar
• D.E.AustJ.P.TerdimanR.F.WillenbucherK.ChewL.FerrellC.FlorendoAltered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancersMod Pathol14120012939
   Web of Science ®Google Scholar
• N.A.WongM.PignatelliBeta-catenin–a linchpin in colorectal carcinogenesis?Am J Pathol1602002389401
   PubMed Web of Science ®Google Scholar
• S.YachidaS.MudaliS.A.MartinE.A.MontgomeryC.A.Iacobuzio-DonahueBeta-Catenin Nuclear Labeling is a Common Feature of Sessile Serrated Adenomas and Correlates with Early Neoplastic Progression Following BRAF ActivationAm J Surg Pathol3312200918231832
   Web of Science ®Google Scholar
• S.C.Cesar WongE.S.Fong LoK.C.LeePrognostic and diagnostic significance of β-Catenin nuclear immunostaining in colorectal cancerClin Cancer Res10200414011408
   Web of Science ®Google Scholar
• T.KawasakiK.NoshoyM.OhnishiY.SuemotoG.J.KirknerzR.DehariCorrelation of B-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancerNeoplasia972007569577
   PubMed Web of Science ®Google Scholar
• T.KitagawaK.MatsumotoA.NagafuchiS.TsukitaH.SuzukiCo-expression of E-cadherin and alpha-catenin molecules in colorectal cancerSurg Today2961999511518
   Web of Science ®Google Scholar
• D.HorstS.ReuL.KrieglT.KirchnerA.JungThe intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancerCancer11510200920632070
   PubMed Web of Science ®Google Scholar
• R.PaiB.SoreghanSzaboIL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinalhypertrophyNat Med82002289293
   PubMed Web of Science ®Google Scholar
• R.PaiT.NakamuraW.S.MoonA.S.TarnawskiProstaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptorsFASEB J17200316401647
   PubMed Web of Science ®Google Scholar
• H.K.LeeS.JeongBeta-catenin stabilizes cyclooxygenase-2 mRNA by interacting with AU-rich elements of 3V-UTRNucleic Acids Res34200657055714
   Web of Science ®Google Scholar
• F.NuñezS.BravoF.CruzatM.MontecinoG.V.De FerrariWnt/β-Catenin Signaling Enhances Cyclooxygenase-2 (COX2) Transcriptional Activity in Gastric Cancer CellsPlos One642011e18562
   Web of Science ®Google Scholar
• Z.H.PengD.S.WanL.R.LiG.ChenZ.H.LuX.J.WuExpression of COX-2 MMP-2 and VEGF in stage II and III colorectal cancer and the clinical significanceHepatogastroentrology581062011369376
   Google Scholar
• M.KobayashiT.HonmaY.MatsudaY.SuzukiR.NarisawaY.AjiokaNuclear translocation of beta-catenin in colorectal cancerBr J Cancer8210200016891693
   PubMed Web of Science ®Google Scholar
• Z.G.LiX.Y.WangJ.L.ChangW.B.XieT.F.LiiuQ.L.ZhangThe establishment of supramolecular immunobead real-time PCR and the identification of Cox-2 as a metastasis-related marker in colorectal carcinomaOncol Rep2832012977984
   PubMed Web of Science ®Google Scholar